Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery

Description

The purpose of the study is to evaluate the surgical outcomes of injecting platelet-rich plasma (PRP) into the vaginal tissue as an adjunct therapy at the time of prolapse surgery

Conditions

Pelvic Organ Prolapse

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of the study is to evaluate the surgical outcomes of injecting platelet-rich plasma (PRP) into the vaginal tissue as an adjunct therapy at the time of prolapse surgery

Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery

Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery

Condition
Pelvic Organ Prolapse
Intervention / Treatment

-

Contacts and Locations

Birmingham

University of Alabama at Birmingham, Birmingham, Alabama, United States, 35249

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Desire surgical treatment via a transvaginal native tissue approach.
  • * Completed child-bearing
  • * Unable to follow-up, not willing to, or unable to participate in the proposed study
  • * Prior pelvic surgery within the past 12 months
  • * Prior anterior/apical suspension procedures
  • * Prior graft augmented prolapse surgery
  • * Pelvic/abdominal radiation
  • * Pelvic mass
  • * History of solid organ malignancy

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Alabama at Birmingham,

Isuzu Meyer, MD, MSPH, PRINCIPAL_INVESTIGATOR, The University of Alabama at Birmingham

Study Record Dates

2028-12-31